You have 9 free searches left this month | for more free features.

Antineoplastic Drugs

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cancer Trial in Jinan (Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs))

Recruiting
  • Cancer
  • Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs)
  • Jinan, Shandong, China
    Shandong Provincial Qianfoshan Hospital
Jul 18, 2022

Nurses Internal Contamination by Antineoplastic Drugs.

Completed
  • Antineoplastic Drugs Contamination Prevalence
  • Nurses urine samples
  • Bordeaux, France
  • +2 more
May 14, 2020

DESIGN OF A SCALE TO MEASURE COMPLIANCE WITH DRUG TREATMENT IN

Unknown status
  • Adherence, Medication
  • Therapeutic Adherence
  • (no location specified)
Oct 2, 2020

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

Recruiting
  • Leukemia
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +9 more
Sep 9, 2022

Multiple Myeloma, Tumor, Plasma Cell, Tumors by Histologic Type Trial in United States (CYNK-001)

Active, not recruiting
  • Multiple Myeloma
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +8 more
May 24, 2022

Safe Infusion Device in Reducing Occupational Exposure of Nurses

Completed
  • Cancer
  • Safe Infusion Device
  • Saint-Priest-en-Jarez, France
    Institut de Cancérologie Lucien Neuwirth
Sep 23, 2019

Chemo-induced Nausea and Vomiting (CINV) Trial in Shanghai (Granisetron Transdermal Delivery System)

Recruiting
  • Chemotherapy-induced Nausea and Vomiting (CINV)
  • Granisetron Transdermal Delivery System
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 19, 2022

Drug-Induced Acute Liver Injury Trial in Tianjin (Bicyclol tablets)

Recruiting
  • Drug-Induced Acute Liver Injury
  • Bicyclol tablets
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Feb 2, 2023

CIPN and it's Impact on Quality of Life in Patients Receiving

Not yet recruiting
  • Chemotherapy-induced Peripheral Neuropathy
    • (no location specified)
    Apr 24, 2023

    Efficacy and Safety of ICIs as First-line Therapy for Advanced

    Not yet recruiting
    • Malignant Tumor
    • +2 more
      • Chongqing, Chongqing, China
        the second affiliated hospital of Army medical university
      May 16, 2023

      Breast Cancer, Gynecologic Cancer, HNSCC Trial in Boston (STX-478, Fulvestrant)

      Recruiting
      • Breast Cancer
      • +3 more
      • Boston, Massachusetts
        Massachusetts General Hospital
      Mar 13, 2023

      Atrial Fibrillation in Patients With Cancer (MAFIC Study)

      Recruiting
      • Cancer
      • Atrial Fibrillation
      • Low molecular weight heparin
      • Thessaloniki, Greece
      • +1 more
      Feb 14, 2022

      Vacuolar ATPase and Drug Resistance of High Grade Gliomas

      Recruiting
      • Glioblastoma Multiforme
        • Monza, Italy
          Azienda Socio Sanitaria Territoriale Monza - Ospedale San Gerard
        Apr 11, 2022

        Oral Complications in Hematological Malignancies

        Not yet recruiting
        • Hematologic Malignancy
          • Assiut, Egypt
            Assiut university
          Mar 6, 2023

          Computation Prediction of Drug Response Based on Omics Data

          Enrolling by invitation
          • Breast Cancer
          • virtual anti-cancer drug
          • Beijing, Beijing, China
            Shuhua Zhao
          Apr 25, 2023

          Reporting of AdVerse Events Associated With AnTicAncerRapy

          Recruiting
          • Cancer
          • Antineoplastic and Immunomodulating Agents
          • Caen, Basse Normandie, France
            Alexandre Joachim
          Jan 4, 2021

          Myocardial Injury and Intestinal Flora Changes Associated With

          Recruiting
          • Cancer Therapy-related Cardiovascular Toxicity
          • Antitumor drugs
          • Beijing, China
            Zhenyu Tian
          Feb 6, 2023

          Dedifferentiated Liposarcoma Patients in China

          Not yet recruiting
          • Dedifferentiated Liposarcoma
            • Beijing, China
              Beijing Jishuitan hospital
            Oct 30, 2023

            Ovarian Cancer Trial in Roma (Blood sample)

            Recruiting
            • Ovarian Cancer
            • Blood sample
            • Roma, Italy
              Policlinico Universitario Agostino Gemelli
            Oct 10, 2023

            Sarcoma Trial in Guangzhou (chidamide and toripalimab)

            Recruiting
            • Sarcoma
            • chidamide and toripalimab
            • Guangzhou, Guangdong, China
              Sun Yat-Sen Univerisity
            Sep 4, 2022

            Localized Muscle Invasive Bladder Urothelial Carcinoma, Muscle-Invasive Bladder Carcinoma Trial in Cleveland (Sacituzumab

            Not yet recruiting
            • Localized Muscle Invasive Bladder Urothelial Carcinoma
            • Muscle-Invasive Bladder Carcinoma
            • Sacituzumab govitecan
            • Adaptive Radiotherapy
            • Cleveland, Ohio
              Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
            Apr 18, 2023

            Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Merkel Cell

            Not yet recruiting
            • Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8
            • +2 more
            • Biopsy
            • +6 more
            • Seattle, Washington
              Fred Hutch/University of Washington Cancer Consortium
            Sep 28, 2023

            Cytokine Release Syndrome, Covid-19 Trial in Sao Luis (Tocilizumab 180 MG/ML, Methylprednisolone Sodium Succinate)

            Terminated
            • Cytokine Release Syndrome
            • Covid-19
            • Tocilizumab 180 MG/ML
            • Methylprednisolone Sodium Succinate
            • Sao Luis, MA, Brazil
              Hospital Sao Domingos
            Mar 14, 2022

            Adenocarcinoma of Stomach Trial in Shanghai (Gentuximab Injection, Gentuximab Injection Placebo)

            Recruiting
            • Adenocarcinoma of Stomach
            • Gentuximab Injection
            • Gentuximab Injection Placebo
            • Shanghai, Shanghai, China
              Shanghai Dongfang Hospital
            Jun 16, 2023

            Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Resectable Head and Neck Squamous Cell Carcinoma Trial in Boston

            Not yet recruiting
            • Head and Neck Squamous Cell Carcinoma
            • +3 more
            • Boston, Massachusetts
            • +1 more
            Feb 11, 2023